ğŸ§¬ GENE OF THE WEEK: UGT1A1

The bilirubin conjugation gene. UGT1A1 variants cause Gilbert's syndrome (benign jaundice) and affect metabolism of key chemotherapy and HIV drugs.

UGT1A1 encodes an enzyme that conjugates bilirubin for excretion and metabolizes certain drugs.

UGT1A1*28 Polymorphism:

*1/*1 (Normal):
âœ… Normal enzyme activity
âœ… Standard bilirubin levels
âœ… Normal drug metabolism
âœ… Standard irinotecan dosing

*28/*28 (Gilbert's Syndrome):
âš ï¸ ~70% reduced enzyme activity
âš ï¸ Elevated bilirubin (usually harmless)
âš ï¸ Irinotecan toxicity risk
âš ï¸ Dose reduction required
âš ï¸ Affects atazanavir levels

Key Drugs Affected:

ğŸ’Š Irinotecan (chemotherapy)
ğŸ’Š Atazanavir (HIV medication)
ğŸ’Š Belinostat
ğŸ’Š Sacituzumab govitecan

Gilbert's syndrome affects 5-10% of population. Usually benign with intermittent mild jaundice, but becomes clinically important when these drugs are prescribed.

ğŸ‘¨â€âš•ï¸ Physicians: Why aren't you using Bioscope.AI to offer true AI-powered precision medicine?

ğŸ§‘ Patients: Why isn't your physician using Bioscope.AI to maximize your healthy longevity?

#GeneOfTheWeek #UGT1A1 #Gilberts #Pharmacogenomics #Bioscope
